Oncolytics Biotech, Inc. (ONCY) Company Profile & Statistics

Oncolytics Biotech, Inc.
ONCY
(Nasdaq - US)
Closed
1.05
+0.01 (+0.96%)
in:usd•As of: Apr 23, 2024 11:40 UTC -4
Open
1.06
High
1.06
Low
1.05

About Oncolytics Biotech, Inc.

CEO

Matthew Coffey

Headquarters

804, 322 - 11 avenue sw

calgary, a0 t2r 0c5, canada

Auditor

Ernst & Young LLP

Employees

Share Holders

195

Website

www.oncolyticsbiotech.com

Industry

biotechnology

Sector

health technology

Company Overview

Oncolytics Biotech, Inc. focuses on the discovery and development of pharmaceutical products for the treatment of a wide variety of human and companion pet cancers. The Company was formed to explore the oncolytic capability of the reovirus, a virus that preferentially replicates in cells with an activated Ras pathway, one of the most common family of genetic defects leading to cancer.

Oncolytics Biotech, Inc. Statistics

Valuation Measures

Market Capitalization ²	79.19M
Enterprise Value	53.33M
Enterprise Value/EBITDA (ttm)	-2.16
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	3.86
Price to Sales (ttm)	N/A
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	0.00%
Operating Margin (ttm)	N/A
Profit Margin (ttm)	0.00%
Return on Equity (ttm)	-105.97%
Return on Invested Capital (ttm)	-106.71%
Return on Assets (ttm)	-72.80%

Income Statement

Revenue (ttm)	0.00
Revenue Per Share (ttm)	0.00
Gross Profit (ttm)	0.00
EBITDA (ttm)³	-24.73M
Net Income Avi to Common (ttm)	-20.56M
Diluted EPS (ttm)	-0.30

Share Statistics

Beta (5Y Monthly)	1.93
52-Week Change	-7.08%
S&P500 52-Week Change	22.51%
S&P500 Member	No
Stock Optionable	No
Total Shares Outstanding ¹	74.42M
Dividend Yield	0.00%
Float ⁴	75.34M
% Held by Insiders	0.10%
% Held by Institutions	6.82%

Balance Sheet

Total Cash (mrq)	25.86M
Total Cash Per Share (mrq)	0.35
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	9.01%
Quick Ratio (mrq)	9.01%
Book Value Per Share (mrq)	0.27

Cash Flow

Operating Cash Flow Per Share (ytd)	-0.31
Free Cash Flow (ytd)	-21.08M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Oncolytics Biotech, Inc.

Trade With A Regulated Broker